Gel for hand and foot syndrome from capecitabine
Part of Skin clinical trials.
This study tests a gel called TAR-0520 for hand and foot syndrome, a painful skin condition that can be caused by the chemotherapy drug capecitabine. The gel is applied to the hands and feet to see if it helps prevent or reduce this side effect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have breast or colorectal cancer.
- Your doctor must plan to treat you with the chemotherapy drug capecitabine.
- You will take capecitabine at a high dose (more than 1000 mg per square meter of body surface) twice a day, for 2 weeks on and 1 week off, and it will be your only chemotherapy.
- You must not have taken capecitabine before.
- You must not have skin lesions (sores, rashes, or open wounds) on your hands or feet.
- You must have a life expectancy greater than 12 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a cooling and compression treatment to your hands and feet during chemotherapy can help prevent nerve damage (neuropathy) caused by the drug paclitaxel. It may be a good option for people with breast cancer who are about to start this type of chemotherapy and want to reduce side effects.
This trial tests if electroacupuncture combined with self-administered acupressure can prevent hand-foot syndrome, a common side effect of the chemotherapy drug capecitabine. It is for people with gastrointestinal or breast cancer who are starting capecitabine for the first time.
This trial tests whether a special cream containing N-acetylcysteine and urea can prevent the painful hand-foot syndrome often caused by the chemotherapy drug capecitabine. If you have breast cancer and are about to start capecitabine, this study may help reduce side effects.
This study tests whether a light-based therapy (photobiomodulation) can reduce pain and skin irritation from hand-foot syndrome/hand-foot skin reaction in people getting chemotherapy or targeted medicines. It may help you heal sooner and feel more comfortable while treatment continues.
This study tests a plaster containing urea to see if it helps treat hand-foot syndrome, a common side effect of chemotherapy that causes redness, swelling, and pain on the hands and feet. It is for people with mild to moderate symptoms who are otherwise doing well.
This trial tests a traditional Chinese medicine hand-foot soak to help with painful side effects of cancer treatment, like hand-foot syndrome and nerve damage in hands or feet. If it works, it could make daily activities more comfortable and improve your quality of life.
Hear when a new Hand and Foot Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.